EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Indications and prescribing patterns of antiseizure medications in children in New Zealand

Shayma Ali iD, James Stanley, Suzanne Davis, Ngaire Keenan, Ingrid E Scheffer iD, Lynette G Sadleir iD

Developmental Medicine & Child Neurology · 2023

DOI: 10.1111/dmcn.15546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2023. Verfasst von Shayma Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand. Hauptthemen laut MEDLINE: Valproic Acid, Seizures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine indications and prescribing patterns for antiseizure medications (ASMs) in children by age, sex, and socioeconomic status.

Method

This retrospective study searched the New Zealand database of ASM prescriptions dispensed to individuals aged 18 years or under during 2015 in three regions of New Zealand (48% paediatric population). Medical records were reviewed by a paediatric neurologist for indication. ASMs were grouped into old or new (1993 onwards).

Results

In total, 2594 children (0 to 18 years, mean age 11 years 2 months, median 12 years; 51% male) were dispensed 3557 ASMs for seizures (76%), pain (6%), headache (5%), mental health (3%), and movement disorders (2%). After 10 years of age, lamotrigine was more likely and valproate less likely to be prescribed in females than males. No sex difference was observed for valproate prescriptions for non‐seizure indications. Topiramate prescriptions increased in adolescent females. Prescriptions for non‐seizure indications increased from 7% in children aged 6 years or under to 31% in 16‐ to 18‐year‐olds. The proportion of children receiving a new ASM compared to an old ASM was greater in children from higher than lower socioeconomic areas.

Interpretation

Our results highlight a need for focused ASM teratogenicity messaging to clinicians prescribing ASMs for non‐seizure indications. In addition, to improve equity of epilepsy care, it is critical for health policies to consider socioeconomic factors that impact on ASM prescribing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidSeizuresAdolescentFemaleHumansChildMaleNew ZealandRetrospective StudiesDatabases, FactualAnticonvulsants

Substanzen

Valproic AcidAnticonvulsants

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.
  • Department of Public Health, University of Otago, Wellington, New Zealand.
  • Department of Neurology, Auckland City Hospital, Auckland, New Zealand.
  • Departments of Medicine and Paediatrics, University of Melbourne, Austin Health and Royal Children's Hospital, Florey and Murdoch Children's Research Institutes, Melbourne, Australia.

ORCID-Profile: Shayma Ali, Ingrid E Scheffer, Lynette G Sadleir

Zitieren

APA

Ali, S., Stanley, J., Davis, S., Keenan, N., Scheffer, I. E., & Sadleir, L. G. (2023). Indications and prescribing patterns of antiseizure medications in children in New Zealand. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.15546

Vancouver

Ali S, Stanley J, Davis S, Keenan N, Scheffer IE, Sadleir LG. Indications and prescribing patterns of antiseizure medications in children in New Zealand. Developmental Medicine & Child Neurology. 2023. doi:10.1111/dmcn.15546

BibTeX
@article{Ali2023,
  author = {Ali, Shayma and Stanley, James and Davis, Suzanne and Keenan, Ngaire and Scheffer, Ingrid E and Sadleir, Lynette G},
  title = {Indications and prescribing patterns of antiseizure medications in children in New Zealand},
  journal = {Developmental Medicine & Child Neurology},
  year = {2023},
  doi = {10.1111/dmcn.15546}
}
Kostenlos starten →